mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Efficient vaccination can be achieved by injections of in vitro transcribed mRNA (ivt mRNA) coding for antigens. This vaccine format is particularly versatile and allows the production of individualised vaccines conferring, T-cell immunity against specific cancer mutations. The CDR3 hypervariable regions of immune receptors (T-cell receptor, TCR or...
Alternative Titles
Full title
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_740ac46bbfb44586b93eb42bb91c79c1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_740ac46bbfb44586b93eb42bb91c79c1
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics13071040
